Stay updated with breaking news from Lung Fact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
* Results support potential for a new treatment option that builds on the benefit of first-line standard of care Tagrisso monotherapy Positive high-level results from the FLAURA2 Phase III trial... | May 17, 2023
Results support potential for a new treatment option that builds on the benefit of first-line standard of care TAGRISSO monotherapy ... | May 17, 2023
Investegate announcements from AstraZeneca PLC, Update on Imfinzi PEARL trial
Investegate announcements from AstraZeneca PLC, Tagrisso approved in Japan for early lung cancer
Late-breaking oral presentation at WCLC features first results from TROPION-Lung02 trial of Daiichi Sankyo and AstraZeneca's TROP2 directed antibody drug conjugate Initial results from the TROPION-Lung02